Decibel Therapeutics (DBTX) Appoints Matthew Kapusta to its Board

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/23/2026

1. META
2. TSLA
3. IBM
4. TXN
5. SAP
6. MRNA
7. CSX
8. QGEN
9. SPCX
10. LRCX

Go back to Decibel Therapeutics (DBTX) Appoints Matthew Kapusta to its Board

Decibel Therapeutics Appoints Matthew Kapusta to its Board of Directors

March 21, 2023 7:01 AM EDT

BOSTON, March 21, 2023 (GLOBE NEWSWIRE) -- Decibel Therapeutics (Nasdaq: DBTX), a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments to restore and improve hearing and balance, today announced the appointment of Matthew Kapusta to its Board of Directors.

We are pleased to welcome Matt to the Decibel Board. He is an accomplished life sciences executive who has played a key role in advancing gene therapy products from the laboratory to patients in need, said Laurence Reid, Ph.D., Chief Executive Officer at Decibel. Matts appointment to the Board provides... More